Literature DB >> 22871684

Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.

Haruto Uchino1, Satoshi Kuroda, Kenji Hirata, Tohru Shiga, Kiyohiro Houkin, Nagara Tamaki.   

Abstract

BACKGROUND AND
PURPOSE: Clinical features and pathophysiology of postoperative hyperperfusion in moyamoya disease are still unclear. This study was aimed to clarify the incidence and time course of postoperative hyperperfusion and to determine the independent predictors of postoperative hyperperfusion in moyamoya disease.
METHODS: This prospective study included 41 patients who underwent surgical revascularization for moyamoya disease. Using (15)O-gas positron emission tomography, hemodynamic and metabolic parameters were quantified before surgery. Using single photon emission computed tomography, cerebral blood flow was serially measured just after surgery and on 2 and 7 days postsurgery. A multivariate logistic regression analysis was conducted to test the effect of multiple variables on postoperative hyperperfusion.
RESULTS: Postoperative hyperperfusion was observed in 29 (50.0%) of 58 operated hemispheres. The incidence of both radiological and symptomatic hyperperfusion was significantly higher in adult patients than in pediatric ones (P=0.026 and P=0.0037, respectively). Hyperperfusion just after surgery more often led to subsequent neurological deficits (P=0.033). A multivariate analysis revealed that preoperative cerebral blood volume increase was an independent predictor of both radiological and symptomatic hyperperfusion after surgery in adult moyamoya disease (OR, 6.6 and 12.3, respectively).
CONCLUSIONS: Postoperative hyperperfusion after surgical revascularization is not rare in moyamoya disease. Adult patients with a cerebral blood volume increase may be at high risk for radiological and symptomatic hyperperfusion after surgery. Careful perioperative management would reduce surgical complications and improve long-term outcome in moyamoya disease.

Entities:  

Mesh:

Year:  2012        PMID: 22871684     DOI: 10.1161/STROKEAHA.112.654723

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

1.  Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease.

Authors:  Haruto Uchino; Ken Kazumata; Masaki Ito; Naoki Nakayama; Satoshi Kuroda; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2020-02-19       Impact factor: 3.042

2.  Cerebrovascular blood pressure autoregulation monitoring and postoperative transient ischemic attack in pediatric moyamoya vasculopathy.

Authors:  Jennifer K Lee; Monica Williams; Michael Reyes; Edward S Ahn
Journal:  Paediatr Anaesth       Date:  2017-12-05       Impact factor: 2.556

3.  Clinical Use of Cerebrovascular Compliance Imaging to Evaluate Revascularization in Patients With Moyamoya.

Authors:  Jennifer M Watchmaker; Blaise deB Frederick; Matthew R Fusco; Larry T Davis; Meher R Juttukonda; Sarah K Lants; Howard S Kirshner; Manus J Donahue
Journal:  Neurosurgery       Date:  2019-01-01       Impact factor: 4.654

Review 4.  Surgical Treatment of Adult Moyamoya Disease.

Authors:  Si Un Lee; Chang Wan Oh; O-Ki Kwon; Jae Seung Bang; Seung Pil Ban; Hyoung Soo Byoun; Tackeun Kim
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.598

5.  Moyamoya angiopathy: early postoperative course within 3 months after STA-MCA-bypass surgery in Europe-a retrospective analysis of 64 procedures.

Authors:  Markus Kraemer; Jasmin Sassen; Rusen Karakaya; Jan Claudius Schwitalla; Jonas Graf; Philipp Albrecht; Hans-Peter Hartung; Rolf R Diehl; Peter Berlit; Rudolf Laumer; Frank Diesner
Journal:  J Neurol       Date:  2018-08-17       Impact factor: 4.849

6.  Acetazolamide-Loaded Dynamic 7T MR Quantitative Susceptibility Mapping in Major Cerebral Artery Steno-Occlusive Disease: Comparison with PET.

Authors:  K Fujimoto; I Uwano; M Sasaki; S Oshida; S Tsutsui; W Yanagihara; S Fujiwara; M Kobayashi; Y Kubo; K Yoshida; K Terasaki; K Ogasawara
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-16       Impact factor: 3.825

7.  Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease.

Authors:  K Sato; M Yamada; H Kuroda; D Yamamoto; Y Asano; Y Inoue; K Fujii; T Kumabe
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-03       Impact factor: 3.825

8.  Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients-case-control study.

Authors:  Masahito Katsuki; Miki Fujimura; Ryosuke Tashiro; Yasutake Tomata; Taketo Nishizawa; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2020-09-24       Impact factor: 3.042

9.  Cerebrovascular autoregulation in pediatric moyamoya disease.

Authors:  Jennifer K Lee; Monica Williams; Jacky M Jennings; Jessica L Jamrogowicz; Abby C Larson; Lori C Jordan; Eugenie S Heitmiller; Charles W Hogue; Edward S Ahn
Journal:  Paediatr Anaesth       Date:  2013-03-18       Impact factor: 2.556

10.  Preoperatively reduced cerebrovascular contractile reactivity to hypocapnia by hyperventilation is associated with cerebral hyperperfusion syndrome after arterial bypass surgery for adult patients with cerebral misery perfusion due to ischemic moyamoya disease.

Authors:  Shinpei Sato; Daigo Kojima; Yasuyoshi Shimada; Jun Yoshida; Kentaro Fujimato; Shunrou Fujiwara; Masakazu Kobayashi; Yoshitaka Kubo; Kenji Yoshida; Kazunori Terasaki; Shouta Tsutsui; Kenya Miyoshi; Kuniaki Ogasawara
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-31       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.